German Government Woos Young Scientists

Getty Images When Stefanie Dimmeler became professor of molecular cardiology in Frankfurt last year, researchers hailed her as one of Germany's youngest tenured scientists. Obtaining a tenured professorship at age 33 may not seem like something out of the ordinary to some US researchers, but Dimmeler beat most of her German colleagues by 10 years. To help make that country more attractive to bright scientists like Dimmeler, Federal Education Minister Edelgard Bulmahn introduced a law in Janu

Written byMartina Habeck
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

When Stefanie Dimmeler became professor of molecular cardiology in Frankfurt last year, researchers hailed her as one of Germany's youngest tenured scientists. Obtaining a tenured professorship at age 33 may not seem like something out of the ordinary to some US researchers, but Dimmeler beat most of her German colleagues by 10 years.

To help make that country more attractive to bright scientists like Dimmeler, Federal Education Minister Edelgard Bulmahn introduced a law in January 2002 that radically changed the academic workplace. The law creates junior professorships, similar to the American system of assistant or associate professors, and it also makes it possible to obtain a professorship after a career in industry.

For the last century, German scientists have routinely remained in postdoctoral purgatory for more than a decade, in a system much criticized as patriarchal. Postdoctoral scientists are assigned to a professor, and they must then acquire yet another ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies